Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiopharmaceuticals
Pharma
Novartis' Pluvicto slows progression in earlier prostate cancer
Novartis also reported an early positive trend in overall survival, although that data point remained immature.
Angus Liuu
Oct 19, 2025 10:30am
Nusano debuts radioisotope production plant in Utah
Aug 26, 2025 9:05am
Nucleus RadioPharma taps former FDA head Stephen Hahn as CEO
Aug 21, 2025 9:09am
Novartis' Pluvicto picks up speed, delivers another trial win
Jul 17, 2025 10:56am
BMS opens RayzeBio radiopharma production site in Indianapolis
Jul 14, 2025 10:40am
Ratio, Ionetix ink separate radiopharmaceutical isotope deals
Jun 23, 2025 11:08am
